Digitalis glycosides. I.
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001702:Biopharmaceutics; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004074:Digitoxin / Q000008:administration & dosage / Q000378:metabolism; D004077:Digoxin / Q000008:administration & dosage / Q000378:metabolism; D006207:Half-Life; D006321:Heart / Q000187:drug effects; D006801:Humans; D007799:Lanatosides / Q000008:administration & dosage / Q000378:metabolism; D010042:Ouabain / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014655:Vascular Resistance / Q000187:drug effects
D004071:Digitalis Glycosides; D007799:Lanatosides; D010042:Ouabain; D004077:Digoxin; D004074:Digitoxin